A detailed history of Patrick M Sweeney & Associates, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Patrick M Sweeney & Associates, Inc holds 26,481 shares of ABBV stock, worth $4.65 Million. This represents 3.84% of its overall portfolio holdings.

Number of Shares
26,481
Previous 26,480 -0.0%
Holding current value
$4.65 Million
Previous $4.54 Billion 15.14%
% of portfolio
3.84%
Previous 3.67%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$163.84 - $199.33 $163 - $199
1 Added 0.0%
26,481 $5.23 Billion
Q2 2024

Jul 17, 2024

BUY
$154.79 - $180.76 $15,633 - $18,256
101 Added 0.38%
26,480 $4.54 Billion
Q1 2024

Apr 25, 2024

BUY
$159.82 - $182.1 $319 - $364
2 Added 0.01%
26,379 $4.8 Billion
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $3.63 Million - $4.09 Million
26,377 New
26,377 $4.09 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Patrick M Sweeney & Associates, Inc Portfolio

Follow Patrick M Sweeney & Associates, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patrick M Sweeney & Associates, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Patrick M Sweeney & Associates, Inc with notifications on news.